healthcare, pharmaceutical industry, investment, rate of return, human capital theory, who,sustainable development, health expenditure, hospital, finished product, api, value chain, gdp, active hospital beds, healthcare partnership, cancer center, radiotherapy

2. drzargari@gmail.com

13. Tamin Pharmaceutical
Investment Company

17. Iranian Pharma Market - Structure (2012)
.
57%
31%
12%
Generic
Brand
OTC

18. Iranian Pharma Market- Supply (2012)
.
96.1%
3.9%
Internally manufactured Imported

19. Iranian Pharma Market- Sales (2012)
Column1
Internally Manufactured
Imported
.
Value
(Billion USD)
Volume
(Billion)
Total Share
(Value)
Total Share
(Volume)
Domestic
Production 3.2 33 64 % 96.1%
Imported 1.8 1.3 36 % 3.9%
Total 5.1 34.3 100% 100%

20. Iranian Pharma Market- Market Growth
Column1
Internally Manufactured
Imported
.
332 418 574 663 832 1,0131,1961,4741,9152,2292,715
3,300
8000
72 107 163 215 321 426 558
764
1,199
1,276
1,531
1,800
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Domestic Production Imported
millionUSD

21. Tamin Pharmaceutical
Investment Company - TPICO
• TPICO was established in 2003 as a corporate entity for the
governance and management of independently managed
pharmaceutical companies in the portfolio of Social Security
Investment Company.

22. TPICO
• Currently TPICO manages 32 subsidiary pharmaceutical
companies which encompass the whole pharma value chain.
TPICO
R&D
API
FP
Distribution
Commercial Trade
Retailing

23. 32 Companies 8000 HR 900 Products 810 FPs 90 APIs
TPICO
FP 34.07% API 70% Dist. 33.3% Vet. 41% Exp. 40%
Generals
Market Share

24. TPICO Value Chain
.
TPICO
R&D API FP Distribution
Trade &
Retailing
One Central
R&D
Ten
Companies
Twelve
Companies
Four
Companies
Three
Companies

25. 4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
22,000
24,000
1385 1386 1387 1388 1389 1390 1391 1392
622
758
945
1190
1488
1695
1977
2264
Annual Sales of TPICO
USD (Million)
2012-2013

26. TPICO International Cooperation

27. Tamin Central R&D
• Biotechnology Dept.
• Peptide & Protein Dept.
• Narcotics Dept.
• Herbal and Natural
Products Dept.
• Drug Design Dept.
• LVHV Dept.
• Chemical Synthesis Dept.
• Nano Drugs
• NDDS

28. Group Pipeline
Ideas
Market
726 Molecules
High Tech Products with
an Annual Market Value
of 1 billion USD

29. Future Projects
.
Development
of high value
medicines for
both domestic
use and exports

30. Future Projects
.
Tamin Pharmaceutical City

31. Future Projects
.
Tamin Plasma Fractionation Plant

32. Future Projects
.
Tamin Human and Veterinary Vaccine Plant